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Abstract
Background: Various drugs have been used to facilitate awake fiberoptic intubation (AFOI). Although fentanyl is probably used
most frequently, magnesium sulfate can provide muscle relaxation without respiratory depression and attenuate hemodynamic
responses.
Methods: We randomly allocated 20 patients of both sexes, aged 18 - 60 years, and ASA status I-II to receive fentanyl 2 µg/kg (group
F) or magnesium sulfate 45 mg/kg (group M) before AFOI. The intubating conditions were evaluated by Ramsay sedation score (RSS),
cough score, post-intubation score, additional topicalization requirement, and hemodynamic response. Oxygen desaturation, air-
way morbidity, recall of procedure, and the patient’s willingness to return for the same kind of anesthesia, if required, were also
studied. Statistical analyses were done using SPSS V. 17.0 software. Numerical data were analyzed using independent and paired
t-tests and categorical data using the chi-square test. P values of < 0.05 were considered significant.
Results: RSS, cough score, post-intubation score, lignocaine dose, airway-related morbidity, and willingness to undergo the same
kind of anesthesia for a second time were comparable between the two groups. Both drugs had comparable effects on hemodynamic
response to intubation. However, the incidence of recall of the procedure was significantly lower in group F (P = 0.003).
Conclusions: The degree of coughing during fiberoptic bronchoscopy, tolerance of the endotracheal tube after intubation, and
the hemodynamic response to intubation were similar after the administration of either fentanyl 2µg/kg or magnesium sulfate 45
mg/kg.
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1. Background
Awake fiberoptic intubation (AFOI) is the gold stan-
dard technique for intubation of patients with an antici-
pated difficult airway, failed intubation, and unstable cer-
vical spine. The success of AFOI is highly dependent on
good patient preparation and safe sedation scheme. Con-
scious sedation not only minimizes the awareness of the
procedure and increases patient acceptance, but also pro-
vides a calm and co-operative patient who is able to fol-
low verbal commands (1). Hemodynamic responses to tra-
cheal intubation are mediated by the autonomic nervous
system and include hypertension, arrhythmias, and tachy-
cardia, attributed to a reflex increase in sympathetic dis-
charge caused by the stimulation of the upper respiratory
tract (2, 3). Various drugs such as benzodiazepines, opioids,
propofol, dexmedetomidine, etc. are used alone or in com-
bination to suppress this pressor response (4), with opi-
oids being the most commonly used drugs. Besides facil-
itating fiberscopy and intubation, they provide analgesia
and suppress coughing. However, there is a risk of respira-
tory depression with consequent hypoxemia.
Magnesium is known to possess muscle-relaxing ef-
fects by reducing acetylcholine release. It acts as a mem-
brane stabilizer by intervening in the activation of mem-
brane Ca-ATPase and Na-K ATPase. Magnesium also seems
to have antinociceptive and anesthetic properties through
its antagonist effect on N-methyl-D-aspartate (NMDA) re-
ceptors (5-7). There remains an ongoing search for an
ideal agent for conscious sedation that ensures sponta-
neous ventilation with a patent airway, patient coopera-
tion, smooth intubating conditions, and stable hemody-
namics without respiratory depression. We hypothesized
that the administration of magnesium sulfate (MgSO4)
may facilitate nasotracheal AFOI.
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2. Objectives
The present study aimed to assess the effectiveness of
MgSO4 in facilitating nasotracheal AFOI and to compare
MgSO4 with intravenous fentanyl by assessing the cough
score, the degree of sedation, the hemodynamic response
to intubation, post-intubation score, patient recall, airway
trauma, and willingness to return as secondary outcomes.
3. Methods
This double-blinded randomized prospective trial was
conducted at the Department of Anesthesiology of a ter-
tiary care center after being approved by the Institutional
Ethics Committee from March 2016 to March 2017. The
study recruited 20 adult patients of both sexes, aged 18 -
60 years, with American Society of Anesthesiologists (ASA)
physical status I-II, and posted for elective surgical proce-
dures under general anesthesia. We excluded patients with
a history of alcohol/drug abuse, allergy to study drugs,
bradycardia, significant cardiovascular, neurological, hep-
atic, renal, and pulmonary diseases, contraindications
to nasal intubation (thrombocytopenia/coagulopathy), re-
cent upper respiratory tract infection, anticipated difficult
airway, and pregnancy. Written informed consent was ob-
tained.
On the morning of the surgery day, patients were ran-
domly allocated to group M (MgSO4) or group F (Fentanyl).
Randomization was done by block randomization using
randomly mixed block sizes. The patients were blinded to
their group allocation. All patients in both groups were
premedicated with alprazolam 0.5 mg tablets on the night
before surgery, ranitidine 150 mg and metoclopramide 10
mg tablets 2 hours before surgery, and intramuscular gly-
copyrrolate 0.2 mg one hour before anesthesia. All patients
received 2 - 3 drops of xylometazoline 0.1% in each nos-
tril for decongestion of the nasal mucosa. The toxic dose
of topical lignocaine was calculated (8.2 mg/kg as recom-
mended by the British Thoracic Society) according to the
weight of the patient. The topicalization of the airway was
done with 4 mL of 4% lignocaine. This lignocaine amount
(160 mg) was subtracted from the maximum allowable lig-
nocaine dose and the safe number of SAYGO boluses was
calculated for each patient. After shifting to the operating
room, intravenous access was secured and standard mon-
itors were attached. A well-lubricated nasopharyngeal air-
way (NPA) was inserted into a nostril with better patency,
followed by administering 1 mg midazolam intravenously.
After 5 minutes, the study drug infusion started and com-
pleted in 10 minutes. Group M received MgSO4 45 mg/kg
and group F received fentanyl 2 µg/kg intravenously. Both
study drugs were diluted in normal saline to a final volume
of 50 mL by an independent anesthesiologist not involved
in the subsequent stages of the study. Fiberscopy was
performed by a consultant anesthesiologist who was rou-
tinely practicing fiberscopy and had performed at least 10
successful fiberoptic nasotracheal intubations on a man-
nequin and 20 on patients. Another investigator made
observations and recorded the data. Both investigators
were blinded to the study drugs and remained constant
throughout the study period.
At the end of the study drug infusion, sedation was
evaluated by the Ramsay sedation scale (RSS) score as 1
(anxious, agitated, or restless), 2 (cooperative, oriented,
and tranquil), 3 (sedated but responding to commands),
4 (asleep, brisk glabellar reflex, or responding to a loud
noise), 5 (asleep, sluggish glabellar reflex, or responding to
a loud noise), and 6 (asleep with no response to a painful
stimulus). The NPA was then removed, the fiberscope
was loaded with an appropriately sized cuffed polyvinyl
chloride endotracheal tube (ETT), and fiberscopy was per-
formed through the selected nostril. Whenever the pa-
tient coughed, additional topicalization was performed
with boluses of 1 mL of lignocaine 2% by the SAYGO tech-
nique (8, 9). One additional bolus was used when vocal
cords were visualized and the total number of required bo-
luses was noted. The number of boluses never exceeded
the predetermined toxic dose. After the proper placement
of the ETT in the trachea, general anesthesia was induced
and the surgery was allowed to proceed.
Intubating conditions were evaluated by the cough
score (10) during fiberscopy on a scale of 0 to 3 (0 = no
cough, 1 = single cough, 2 = persistent cough lasting < 5
seconds, and 3 = persistent cough lasting ≥ 5 seconds or
bucking). The tolerance to intubation was evaluated by the
post-intubation score (11) after the placement of the ETT in
the trachea as score 1 (co-operative), 2 (minimal resistance),
and 3 (severe resistance). The mean, systolic, and diastolic
blood pressures (MAP, SBP, DBP), heart rate (HR), and arte-
rial oxygen saturation (SpO2) were noted at six time-points:
T0 (baseline), T1 (after completion of study drug infusion),
T2 (immediately after intubation), T3, T4, T5, T6, and T7 for
every 1 minute for the next 5 minutes, and T8 (10 minutes
after intubation). Any trauma/bleeding event due to intu-
bation was noted. The patients were followed up 24 hours
post-surgery and enquired about sore throat/discomfort,
the ability to recall the procedure of AFOI, and their willing-
ness to undergo the same kind of anesthesia again if nec-
essary. The recall was graded as no recollection, vague rec-
ollection (not remembering the entire sequence of events
but recalling ≤ 2 events when asked specifically), recall
of some details (not remembering the entire sequence of
events but recalling > 2 events when asked specifically),
and recall of all details.
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The sample size selection was based on the results of
previous studies (11) taking the cough score as the primary
variable, assuming that MgSO4 was as good as dexmedeto-
midine in ameliorating the pressor responses to anesthet-
ics and surgical manipulations (12), and that a cough score
of ≤ 2 would provide favorable intubation conditions (10).
A sample size of 6 patients in each group was calculated
to achieve a power of 0.8 and type one error of 0.05. Ten
patients were recruited in each group to account for attri-
tion. Data were collected and analyzed using SPSS V. 17.0
software. The secondary outcome variables included the
sedation score, hemodynamics, and post-intubation score.
The numerical data were expressed as means ± SD and
categorical data were put into tables. The numerical data
were compared between the two groups using the inde-
pendent t-test and within the same group using the paired
t-test. The categorical data were compared between the
two groups using the chi-square test. A P value of < 0.05
was considered statistically significant.
4. Results
Overall, 26 patients took part in the study. There were
six dropouts. The demographic characteristics were com-
parable in the two groups (Table 1).
The RSS scores were similar in both groups (P = 0.214).
The cough score, i.e., the degree of coughing during
fiberscopy (P = 0.952) and the tolerance to intubation, as
evaluated by the post-intubation score, (P = 0.890) were
comparable between the groups (Table 2).
The mean number of additional boluses of lignocaine
required during AFOI was 3.30± 1.89 in group F and 4.50±
1.90 in group M (P = 0.174). Both groups were also similar in
the dose of lignocaine used for airway topicalization, calcu-
lated as 1/3rd of the nebulization dose, i.e., 1/3× 160 mg = 53
mg plus 20 mg on NPA plus 20 mg per the bolus dose of lig-
nocaine (1 mL, 2%). The mean dose of lignocaine used was
139 ± 1.89 mg in group F and 163 ± 1.90 mg in group M (P =
0.174), which did not exceed the toxic dose in any patient.
Table 1. Patient Characteristicsa b
Patient characteristics Group F Group M P Value
Age, y 34.40 ± 11.24 29.30 ± 9.35 0.284
Height, cm 168.40 ± 8.81 167.90 ± 13.27 0.922
Weight, kg 58.60 ± 7.20 61.10 ± 10.84 0.551
BMI, kg/m2 20.88 ± 3.15 22.08 ± 4.44 0.495
ASA grade I 100 100 -
MPC 2.10 ± 0.74 1.80 ± 0.92 0.431
MO > 3 cm 100 100 -
aValues are expressed as mean ± SD or percent.
bThe patient characteristics were comparable in both groups.
Table 2. RSS, Cough Score, and Post-Intubation Scorea , b
Group F Group M P Value
RSS 0.214
1 0 (0) 1 (10)
2 6 (60) 8 (80)
3 4 (40) 1 (10)
Cough Score 0.952
0 1 (10) 1 (10)
1 3 (30) 2 (20)
2 3 (30) 3 (30)
3 3 (30) 4 (40)
Post intubation Score 0.89
1 5 (50) 6 (60)
2 4 (40) 3 (30)
3 1 (10) 1 (10)
aRSS, cough score, and post-intubation score were comparable in both groups.
bValues are expressed as No. (%).
The baseline hemodynamic parameters were compara-
ble. Hemodynamic responses to intubation were seen in
both groups with maximum values of BP and HR seen at T2
(immediately after intubation). The sympathetic response
to intubation led to a 5% rise in MAP in group F and 15%
rise in group M (P = 0.320) and a rise of 35% in HR in group
F and 19% in group M (P = 0.583) (Table 3; Figures 1 to 4);
however, the differences were not significant. All patients
maintained oxygen saturation throughout the procedure
without any episodes of desaturation. The incidence of
any intubation-related upper airway trauma/bleeding and
postoperative sore throat was comparable in both groups
with two cases of mild trauma in group F and three cases
in group M (P = 1.000). Two patients complained of mild
sore throat and one of moderate sore throat in group F
while no patient complained of sore throat in group M (P
= 0.171). Willingness to return for a similar procedure was
comparable in both groups (P = 0.081). However, the recall
of the procedure of awake intubation was significantly less
in group F with 80% of patients having no or only vague
recollection of the events while 60% of patients in group
M could recall the details of the procedure (P = 0.003) (Ta-
ble 4).
5. Discussion
We compared the efficacy of intravenous fentanyl 2
µg/kg and magnesium sulfate 45 mg/kg as premedicants
in AFOI by the nasotracheal route and found compara-
ble intubation conditions and similar tolerance to the tra-
cheal tube after intubation in both groups. However, the
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Table 3. Hemodynamic Response to Intubation
T0 T1 T2 T3 T4 T5 T6 T7 T8
SBP, mmHg
Group F 128.60 ± 7.76 123.10 ± 7.25 125.70 ± 17.16 113.80 ± 19.46 107.80 ± 17.78 105.70 ± 12.02 102.80 ± 15.28 101.10 ± 10.08 104.60 ± 9.77
Group M 123.90 ± 6.84 118.40 ± 14.00 140.60 ± 22.41 119.10 ± 13.02 121.90 ± 32.05 117.60 ± 31.58 104.90 ± 11.62 102.50 ± 12.45 103.00 ± 11.83
P value 0.168 0.358 0.159 0.483 0.240 0.280 0.733 0.785 0.745
DBP, mmHg
Group F 83.50 ± 5.44 79.90 ± 5.24 85.10 ± 14.73 71.70 ± 13.87 65.70 ± 10.98 65.60 ± 9.55 64.00 ± 8.59 63.20 ± 8.27 67.20 ± 7.87
Group M 81.90 ± 6.37 75.80 ± 9.72 83.50 ± 6.28 77.10 ± 12.26 73.20 ± 12.02 67.50 ± 10.12 65.40 ± 8.36 63.90 ± 10.50 63.10 ± 9.49
P value 0.339 0.255 0.756 0.368 0.216 0.671 0.716 0.870 0.307
MAP, mmHg
Group F 96.70 ± 7.09 93.00 ± 6.98 98.40 ± 15.83 86.30 ± 15.38 79.80 ± 12.32 79.00 ± 8.78 77.20 ± 9.51 74.20 ± 8.01 78.50 ± 7.14
Group M 94.40 ± 5.50 90.50 ± 10.22 104.10 ± 10.72 91.90 ± 13.76 83.90 ± 10.33 81.70 ± 8.56 78.90 ± 8.31 76.90 ± 9.67 78.20 ± 9.88
P value 0.428 0.531 0.415 0.402 0.431 0.495 0.675 0.505 0.939
HR, bpm
Group F 90.50 ± 23.73 84.40 ± 23.28 114.50 ± 16.47 96.30 ± 11.59 89.60 ± 15.27 88.70 ± 13.23 83.90 ± 14.63 83.30 ± 11.69 80.40 ± 17.21
Group M 92.80 ± 16.11 92.0 ± 11.79 110.00 ± 25.27 94.90 ± 18.10 94.00 ± 19.17 86.20 ± 17.06 81.90 ± 18.89 80.50 ± 17.68 78.80 ± 12.16
P value 0.803 0.369 0.643 0.839 0.577 0.719 0.794 0.681 0.813
Table 4. Incidence of Recall of the Procedurea
Recall Group F Group M P Value
No 1 4
0.003
Vague recollection 7 0
Some details 0 5
Yes 2 1
aThe incidence of recall was more in group M (P = 0.003).
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Figure 1. Trends in SBP
degree of recall of the awake intubation procedure was sig-
nificantly less in group F.
In patients subjected to AFOI, one can frequently ob-
serve anxiety, hypertension, and tachycardia associated
with coughing and bucking on the ETT. Their safe attenu-
ation is important, especially in patients with the cardiac
or cerebrovascular disease where maintenance of hemo-
dynamic stability and adequate oxygenation and venti-
lation are necessary without compromising safety. Vari-
ous drugs and their combinations have been evaluated to
achieve conscious sedation during AFOI. Fentanyl provides
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Figure 2. Trends in DBP
Comparison of MAP between 
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Figure 3. Trends in MAP
sedation and analgesia along with hemodynamic stabil-
ity. Opioids are also known to suppress coughing that pro-
vides an additional advantage when the manipulation of
the airway is required in awake patients; however, their
use is associated with the risks of respiratory depression,
nausea, vomiting, and chest wall rigidity. MgSO4, on the
other hand, provides hemodynamic stability and some de-
gree of muscle relaxation via decreased catecholamine re-
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Comparison of HR between Group F 
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Figure 4. Trends in HR
lease and antagonism at NMDA receptors. It is unlikely
to cause significant sedation or respiratory depression,
which may be advantageous in the truly difficult airway pa-
tients or in patients with a full stomach and at risk of aspi-
ration. The muscle relaxant properties of MgSO4 may help
in attenuating the coughing and bucking associated with
fiberscopy and intubation in awake patients, leading to re-
duced cough scores. This, along with the hemodynamic
stability associated with its use, makes MgSO4 an attractive
option for facilitating intubation in awake patients.
Mondal et al. (11) reported that fentanyl 2 µg/kg dur-
ing AFOI provided satisfactory intubating conditions and
“arousable” sedation without respiratory depression. We
chose to use this dose in the fentanyl group. Unlike fen-
tanyl, MgSO4 is not usually associated with significant se-
dation. However, previous studies reported some sedation
after the use of MgSO4 (13, 14). In our study, we also ob-
served a comparable degree of sedation in both groups
that was sufficient to allow for AFOI (RSS≥ 2). The sedative
action of MgSO4 can be attributed to central NMDA antag-
onism.
At the studied doses, the degree of coughing was also
similar in both groups. Various studies have demonstrated
the cough-suppressing ability of opioids (15, 16). Although
MgSO4 is not known to possess cough-suppressing proper-
ties, a study by Elgebaly and Eldabaa (12) showed contra-
dictory results. They compared the ease of fiberoptic in-
tubation after administration of MgSO4 45 mg/kg versus
midazolam 0.07 mg/kg and concluded that fiberoptic na-
sotracheal intubation was easier and faster in the MgSO4
group than in the midazolam group, without hemody-
namic or respiratory adverse effects. They did not study
the degree of coughing but coughing and bucking should
have contributed to difficulty during fiberoptic intuba-
tion. This cough-suppressing ability of MgSO4 can be at-
tributed to the sedative and muscle relaxant properties
of magnesium, leading to an inability to sustain a cough.
Higher doses of MgSO4 may lead to respiratory muscle
weakness, which occurs at plasma levels of 5 to 6.5 mmol/L
but this plasma concentration is achieved only with pro-
longed continuous infusions or at very high doses (17, 18)
that was not the case in our study. None of the patients
showed the signs of muscle weakness and we did not con-
sider it necessary to monitor serum Mg levels after the use
of a single loading dose.
Previous studies reported that fentanyl 2µg/kg admin-
istered 5 minutes before tracheal intubation was effective
(in dose and time) to minimize the hemodynamic changes
and achieve adequate conditions for the shortest intuba-
tion time during fiberoptic bronchoscopy (19, 20). Elgebaly
and Eldabaa (12) in patients undergoing elective nasotra-
cheal AFOI concluded that MgSO4 45 mg/kg led to easy, fast
intubation without adverse hemodynamic or respiratory
effects. We used a similar dose in our study and achieved
hemodynamic stability. The maximum rise in hemody-
namics was seen immediately post-intubation. Although
both study drugs were able to obtund the hemodynamic
response to intubation to a similar extent, the rise in the
HR was obtunded more by MgSO4 while the rise in BP was
obtunded more by fentanyl.
On the day after surgery, the patients were asked how
much they remembered the procedure. The patients in the
magnesium group had a higher incidence of recall (Table
4) and could remember more the details of the procedure
than the fentanyl group (P = 0.003). Although fentanyl is
not known to cause amnesia, it does cause significant anx-
iolysis (21). The anxiolytic effects of fentanyl, when com-
bined with the anxiolytic and anterograde amnesia effects
of midazolam, may have resulted in significantly less recall
in the fentanyl group than in the MgSO4 group. However,
the fact that all patients in both groups received midazo-
lam may be a confounding factor when studying the de-
gree of amnesia and anxiolysis induced by the study drugs.
The MgSO4 use during anesthesia provides smooth
muscle relaxation and hemodynamic stability (5-7). We hy-
pothesized that the muscle relaxation activity of MgSO4
and its hemodynamic stability with lacked or minimal se-
dation may make it an ideal drug for use in patients with
a difficult airway requiring AFOI. Although the employed
dose of MgSO4 (45 mg/kg) provided hemodynamic stabil-
ity similar to that provided by fentanyl 2 µg/kg, it was un-
able to cause better suppression of the cough reflex, as it
was similar in both study groups. The selected sample size
was calculated assuming that magnesium is as effective
as dexmedetomidine (22) in ameliorating the pressor re-
sponses to anesthetics and surgical manipulations, as both
MgSO4 and dexmedetomidine have been found to be ef-
fective in suppressing coughing and providing good in-
tubation conditions during AFOI in separate studies (11,
12). Further studies are required to compare MgSO4 and
dexmedetomidine at various doses for this purpose. More-
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over, we studied only single doses of both study drugs. The
use of higher doses of MgSO4 along with the monitoring
of serum Mg levels may allow us to achieve better intu-
bating conditions without compromising patient safety.
Thus, further dose-response studies are required to find
the optimum dose of MgSO4 facilitating AFOI.
5.1. Conclusions
The study showed that fentanyl 2 µg/kg and MgSO4 45
mg/kg are similar in the response of patients to the AFOI
procedure by the nasal route as evaluated by the degree of
coughing during fiberoptic bronchoscopy, tolerance of the
endotracheal tube after intubation, and the hemodynamic
response to intubation.
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